[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360733-105":59,"doc-detail-360733-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","relationship-between-ptbp1-and-pancreatic-cancer-based-on-microrna-and-behavior-during-tyms-mediated-carcinogenesis","Relationship Between PTBP1 and Pancreatic Cancer Based on microRNA and Behavior During TYMS-Mediated Carcinogenesis","","Polypyrimidine tract-binding protein 1, an alternative splicing factor, drives cancer-associated metabolic reprogramming. Although organ-enriched microRNAs regulate PTBP1, its contribution to pancreatic tumor progression remains unclear. This study defines a functional relationship between PTBP1-associated microRNAs and PTBP1 during pancreatic cancer carcinogenesis. miR-216b-5p was downregulated in patient samples and directly suppressed PTBP1 via the 3′ UTR, reducing proliferation. Integrated proteomic analyses identified thymidylate synthase as a novel downstream target linked to splicing-related mechanisms, and its high expression correlated with poor prognosis. PTBP1 and TYMS silencing induced cell-cycle arrest, supporting a PTBP1–miR-216b-5p–TYMS regulatory axis beyond metabolic control.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/relationship-between-ptbp1-and-pancreatic-cancer-based-on-microrna-and-behavior-during-tyms-mediated-carcinogenesis/360733/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/relationship-between-ptbp1-and-pancreatic-cancer-based-on-microrna-and-behavior-during-tyms-mediated-carcinogenesis/360733.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does PTBP1 play in pancreatic cancer progression?","Question",{"text":112,"@type":113},"PTBP1 is described as an alternative splicing factor that regulates metabolic reprogramming and has a broader function in tumor progression via downstream targets beyond metabolism.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does miR-216b-5p relate to PTBP1 expression?",{"text":117,"@type":113},"miR-216b-5p is typically pancreas-enriched but is significantly downregulated in pancreatic cancer samples; it directly binds the 3′ UTR of PTBP1 mRNA to suppress PTBP1 expression and inhibit proliferation.",{"name":119,"@type":110,"acceptedAnswer":120},"Which downstream molecule was identified and what was its clinical relevance?",{"text":121,"@type":113},"Thymidylate synthase is identified as a novel downstream target of PTBP1, is elevated in pancreatic cancer tissues, and correlates with poor prognosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360733,1790192978,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cancer Science  \nORIGINAL ARTICLE  OPEN ACCESS   \nCarcinogenesis  \nRelationship Between PTBP1 and Pancreatic Cancer Based on microRNA and Behavior During TYMS-Mediated Carcinogenesis  \nShigenori Suzuki1 | Hiroaki Hase2 | Yosuke Inomata1  | Jun Arima1 | Kentaro Jingushi2  | Atsushi Tomioka1 | Nao Kawaguchi1  | Hiroki Hamamoto1 | Ryo Tanaka1 | Yoshiro Imai1 | Mitsuhiro Asakuma1 | Tomohito Tanaka3  | Kazutake Tsujikawa4 | Kohei Taniguchi1,3  | Sang-Woong Lee1  \n1Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan | 2Laboratory of Stem Cell Regeneration and Adaptation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Osaka, Japan | 3Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan | 4Compound Library Screening Center, Graduate School of Pharmaceutical Sciences, The University of Osaka, Suita, Osaka, Japan  \nCorrespondence: Kohei Taniguchi ([kohei.taniguchi@ompu.ac.jp](kohei.taniguchi@ompu.ac.jp))  \nReceived: 19 December 2025 | Revised: 8 April 2026 | Accepted: 13 April 2026  \nKeywords: alternative splicing | microRNA | pancreatic cancer | polypyrimidine tract-binding protein 1 | thymidylate synthase  \nABSTRACT  \nPolypyrimidine tract-binding protein 1, an alternative splicing factor, drives cancer-associated metabolic reprogramming by modulating pyruvate kinase M splicing. Although organ-abundant microRNAs (miRs) regulate this protein, its role in tumor progression remains unclear. Therefore, we investigated the functional relationship between polypyrimidine tract-binding protein 1-associated microRNAs and this protein in pancreatic cancer to identify pancreas-enriched microRNAs and explore polypyrimidine tract-binding protein 1 function beyond metabolic regulation. The expression of miR-216b-5p, which is typically pancreas-enriched, was significantly downregulated in clinical pancreatic cancer samples, whereas polypyrimidine tract-binding protein 1 expression was markedly upregulated. Mechanistically, miR-216b-5p directly binds to the 3′ UTR of polypyrimidine tract-binding protein 1 mRNA, thereby suppressing its expression and inhibiting cancer cell proliferation. Proteomic analysis, integrated with publicly available individual-nucleotide resolution UV crosslinking and immunoprecipitation data, identified thymidylate synthase as a novel downstream target of polypyrimidine tract-binding protein 1, likely regulated via splicingrelated RNA-level mechanisms. Thymidylate synthase expression was also elevated in pancreatic cancer tissues and correlated with poor prognosis. Functional assays revealed that polypyrimidine tract-binding protein 1 and thymidylate synthase silencing induced cell cycle arrest. Our findings uncover a previously unrecognized miR-216b-5p/polypyrimidine tract-binding protein 1/ thymidylate synthase regulatory axis that promotes pancreatic cancer progression and establish polypyrimidine tract-binding protein 1 as a central molecular regulator of tumor biology beyond its metabolic role.  \n1 | Introduction  \nPancreatic cancer (PC) is the seventh leading cause of cancerrelated death worldwide. Global trends indicate a steady increase  \nin its incidence, which is expected to become the second leading cause of cancer-related mortality in Western countries [1] . PC is typically diagnosed at an advanced stage, resulting in one of the lowest 5-year survival rates (2%–9%) of all cancers [2] . In Japan,  \n\n| Abbreviations: iCLIP, individual-nucleotide resolution crosslinking and immunoprecipitation; miRNA, miR, microRNA; NMD, nonsense-mediated mRNA decay; PC, pancreatic cancer; PKM, pyruvate kinase M; PTBP1, Polypyrimidine tract-binding protein 1; TYMS, thymidylate synthase. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribu","cbCaib89OHIfda4J","https://ap.wps.com/l/cbCaib89OHIfda4J","pdf",4173180,13,"English","# Introduction\n## Pancreatic cancer burden and unmet needs\n## MicroRNAs in cancer biology\n## Prior work linking PTBP1 to cancer energy metabolism","[{\"question\":\"What role does PTBP1 play in pancreatic cancer progression?\",\"answer\":\"PTBP1 is described as an alternative splicing factor that regulates metabolic reprogramming and has a broader function in tumor progression via downstream targets beyond metabolism.\"},{\"question\":\"How does miR-216b-5p relate to PTBP1 expression?\",\"answer\":\"miR-216b-5p is typically pancreas-enriched but is significantly downregulated in pancreatic cancer samples; it directly binds the 3′ UTR of PTBP1 mRNA to suppress PTBP1 expression and inhibit proliferation.\"},{\"question\":\"Which downstream molecule was identified and what was its clinical relevance?\",\"answer\":\"Thymidylate synthase is identified as a novel downstream target of PTBP1, is elevated in pancreatic cancer tissues, and correlates with poor prognosis.\"}]","Relationship Between PTBP1 and Pancreatic Cancer Based on microRNA and Behavior During TYMS-Mediated Carcinogenesis | PDF",1790141369,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe7605e730a46d6ec3f62e57996d9962.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf36e902d617ffeb0c701400b4b49e98.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f742b3ab76c3180b99d57967c4f3d19b.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6773bebd4e196cfc292a3ba1b1e297cd.webp",980,1287]